SEC Filing Details
Document Details
Form
Filing Date
Jan 4, 2024
Document Date
Jan 4, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Werewolf Therapeutics, Inc.
Issuer
Werewolf Therapeutics, Inc.
Filer
ATKINS MICHAEL B.